Literature DB >> 14564523

Constitutive nitric oxide synthases in rat pancreatic islets: direct imaging of glucose-induced nitric oxide production in beta-cells.

Sachiko Nakada1, Tomohisa Ishikawa, Yuri Yamamoto, Yukiko Kaneko, Koichi Nakayama.   

Abstract

The production of nitric oxide (NO) by constitutive nitric oxide synthase (NOS) was investigated in isolated rat pancreatic islets and dispersed beta-cells. Double-immunocytochemical analyses with a confocal microscope demonstrated the presence of NOS1 in alpha-, beta-, delta-, and PP-cells and that of NOS3 in beta-, delta-, and PP-cells, but not alpha-cells, in the isolated rat islets. Image analyses with the NO-reactive fluorescence dye DAF-2 clearly showed that an elevation in glucose concentrations from 0 to 11.1 mM increased intracellular NO in most cells of the isolated islets. The glucose-induced elevation of intracellular NO in the islet cells was abolished in the presence of the Ca2+ channel blocker nicardipine and after treatment with the NOS inhibitor NG-nitro-L-arginine. Similarly, the ATP-sensitive K+ channel blocker tolbutamide, which elevates intracellular Ca2+ concentrations, increased DAF-2 fluorescence in most cells of the isolated islets. In isolated beta-cells, 11.1 mM glucose increased DAF-2 fluorescence, which was suppressed by NG-nitro-L-arginine and by reducing the glucose concentration to 0 mM. DAF-2 fluorescence in beta-cells was also increased by 50 mM K+, which was suppressed by NG-nitro-L-arginine. These results suggest that NOS1 and NOS3 are present in rat pancreatic beta-cells, and that glucose produces NO by Ca(2+)-dependent activation of the constitutive NOS isoforms.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14564523     DOI: 10.1007/s00424-003-1176-y

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  32 in total

1.  Nitric oxide induces intracellular Ca2+ mobilization and increases secretion of incorporated 5-hydroxytryptamine in rat pancreatic beta-cells.

Authors:  N J Willmott; A Galione; P A Smith
Journal:  FEBS Lett       Date:  1995-09-04       Impact factor: 4.124

2.  Nitric oxide donor SIN-1 inhibits insulin release.

Authors:  A Sjöholm
Journal:  Am J Physiol       Date:  1996-10

3.  Morphological evidence for the existence of nitric oxide and carbon monoxide pathways in the rat islets of Langerhans: an immunocytochemical and confocal microscopical study.

Authors:  P Alm; P Ekström; R Henningsson; I Lundquist
Journal:  Diabetologia       Date:  1999-08       Impact factor: 10.122

4.  Islet constitutive nitric oxide synthase: biochemical determination and regulatory function.

Authors:  A Salehi; M Carlberg; R Henningson; I Lundquist
Journal:  Am J Physiol       Date:  1996-06

5.  A neuronal isoform of nitric oxide synthase expressed in pancreatic beta-cells controls insulin secretion.

Authors:  A D Lajoix; H Reggio; T Chardès; S Péraldi-Roux; F Tribillac; M Roye; S Dietz; C Broca; M Manteghetti; G Ribes; C B Wollheim; R Gross
Journal:  Diabetes       Date:  2001-06       Impact factor: 9.461

6.  Arginine-induced insulin release is decreased and glucagon increased in parallel with islet NO production.

Authors:  R Henningsson; I Lundquist
Journal:  Am J Physiol       Date:  1998-09

7.  Insulin secretion from pancreatic B cells caused by L-arginine-derived nitrogen oxides.

Authors:  H H Schmidt; T D Warner; K Ishii; H Sheng; F Murad
Journal:  Science       Date:  1992-02-07       Impact factor: 47.728

8.  Nitric oxide is not involved in the initiation of insulin secretion from rat islets of Langerhans.

Authors:  P M Jones; S J Persaud; T Bjaaland; J D Pearson; S L Howell
Journal:  Diabetologia       Date:  1992-11       Impact factor: 10.122

9.  Influence of nitric oxide synthase inhibition, nitric oxide and hydroperoxide on insulin release induced by various secretagogues.

Authors:  G Panagiotidis; B Akesson; E L Rydell; I Lundquist
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

10.  Detection and imaging of nitric oxide with novel fluorescent indicators: diaminofluoresceins.

Authors:  H Kojima; N Nakatsubo; K Kikuchi; S Kawahara; Y Kirino; H Nagoshi; Y Hirata; T Nagano
Journal:  Anal Chem       Date:  1998-07-01       Impact factor: 6.986

View more
  8 in total

Review 1.  Free radicals and the pancreatic acinar cells: role in physiology and pathology.

Authors:  M Chvanov; O H Petersen; A Tepikin
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-12-29       Impact factor: 6.237

2.  Dual effect of nitric oxide on ATP-sensitive K+ channels in rat pancreatic beta cells.

Authors:  Takaaki Sunouchi; Kimiaki Suzuki; Koichi Nakayama; Tomohisa Ishikawa
Journal:  Pflugers Arch       Date:  2008-02-01       Impact factor: 3.657

Review 3.  Oxidative stress and beta-cell dysfunction.

Authors:  Gisela Drews; Peter Krippeit-Drews; Martina Düfer
Journal:  Pflugers Arch       Date:  2010-07-23       Impact factor: 3.657

4.  Role of nitric oxide on purinergic signalling in the cochlea.

Authors:  Narinobu Harada
Journal:  Purinergic Signal       Date:  2010-06-08       Impact factor: 3.765

5.  Stimulus-induced S-nitrosylation of Syntaxin 4 impacts insulin granule exocytosis.

Authors:  Dean A Wiseman; Michael A Kalwat; Debbie C Thurmond
Journal:  J Biol Chem       Date:  2011-03-10       Impact factor: 5.157

6.  Microfluidic device for multimodal characterization of pancreatic islets.

Authors:  Javeed Shaikh Mohammed; Yong Wang; Tricia A Harvat; Jose Oberholzer; David T Eddington
Journal:  Lab Chip       Date:  2008-10-21       Impact factor: 6.799

Review 7.  Human Nitric Oxide Synthase-Its Functions, Polymorphisms, and Inhibitors in the Context of Inflammation, Diabetes and Cardiovascular Diseases.

Authors:  Magdalena Król; Marta Kepinska
Journal:  Int J Mol Sci       Date:  2020-12-23       Impact factor: 5.923

8.  Nutrient-stimulated insulin secretion in mouse islets is critically dependent on intracellular pH.

Authors:  Subhadra C Gunawardana; Jonathan V Rocheleau; W Steven Head; David W Piston
Journal:  BMC Endocr Disord       Date:  2004-06-11       Impact factor: 2.763

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.